Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
6 Results Found
AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.
AHA Comments on the SUPPORT for Patients and Communities Reauthorization Act
AHA comments on the SUPPORT for Patients and Communities Reauthorization Act.
AHRMM LUC Comments to the FDA’s Communications About the Safety of Medical Devices
The AHRMM LUC members submitted public comments and recommendations at the FDA's November 2020 meeting related to the need to include the UDI in the recall process. They highlighted the prototype recall database and electronic submission form, as well as survey data supporting its creation.
Letter: AHA urges CMS to issue ligature risk guidance for hospitals
On behalf of our approximately 5,000 hospitals and health system members, the American Hospital Association (AHA) requests immediate clarification of the Centers for Medicare & Medicaid Service
AHA Comments on CMS Proposed Guidance on Ligature Risk
AHA comments on the Centers for Medicare & Medicaid Services’ proposed guidance on ligature risk.
AHRMM Comment Letter to FDA RE: “Modernizing FDA’s Data Strategy”
In September 2019, FDA announced its Technology Modernization Actio